Dr. Ryan Corte discusses the introduction of Essilor's Stellest lenses, the first spectacle lens in the US proven to slow pediatric myopia progression. He explores the increasing prevalence of myopia, its risk factors, and the importance of proactive myopia management in optometry. Dr. Corte shares insights on how to effectively incorporate Stellest lenses into clinical practice, the science behind their design, and the benefits of myopia control. He emphasizes the need for patient education, proper billing practices, and the importance of ongoing monitoring and follow-up care for myopic patients.

Chapters

00:00 Introduction to Essilor's Stellest Lenses

01:05 Understanding Myopia and Its Risks

08:57 How Stellest Lenses Work

11:21 The Importance of Myopia Management

14:13 Implementing Myopia Control in Practice

19:52 Patient Education and Consent Forms

22:51 Best Practices for Myopia Management

Takeaways

• Essilor's Stellest lens is the first US spectacle lens proven to slow myopia progression.
• Myopia is increasingly recognized as a disease process rather than just a refractive error.
• The prevalence of myopia is rising, with significant implications for children's eye health.
• Proactive management and early detection of myopia are crucial for long-term outcomes.
• Screen time and lack of outdoor activity are significant risk factors for myopia in children.
• Stellest lenses offer a low-barrier treatment option for myopic children.
• Data shows Stellest lenses can slow myopia progression by 71%.
• Patient education is essential for successful myopia management.
• Implementing a structured myopia management protocol can enhance practice efficiency.
• The optometry profession has a unique opportunity to improve pediatric eye care through myopia management.